Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients.
Leukemia
; 28(3): 696-8, 2014 Mar.
Article
in En
| MEDLINE
| ID: mdl-24186004
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Transfusion
/
Myelodysplastic Syndromes
/
Erythropoietin
/
Hydroxamic Acids
/
Indoles
Limits:
Humans
Language:
En
Journal:
Leukemia
Year:
2014
Document type:
Article